California, 17 other states reach $5.7B settlement with Walgreens over opioid epidemic

Judge rules Walgreens contributed to San Francisco's opioid crisis

SACRAMENTO – California Attorney General Rob Bonta, alongside 17 other attorneys general, announced a $5.7 billion settlement agreement with the pharmacy retailer Walgreens for their alleged contribution to the opioid epidemic.

The settlement reached Monday resolves a multistate lawsuit alleging Walgreens fueled and profited from the opioid addiction crisis by dispensing substances without proper oversight.

The abatement funds, which will be split amongst participating states, may bring in over $500 million to California's ongoing efforts to provide treatment and services to those addicted to opioids.

"This settlement is another win in our ongoing fight to bring help and healing to California communities harmed by the opioid crisis," said Bonta. "To all those struggling with substance abuse disorders, to all those desperately in need of treatment and recovery options—help is on the way."

Walgreens also has to satisfy court-ordered requirements to help prevent another substance abuse crisis from occurring again. The company agreed to create a program to train employees on drug diversion prevention, investigate "suspicious" prescriptions before dispensing them and allow for site visits at pharmacy locations.

Walgreens also agreed to provide sales data from its distributor to drug manufacturers, in efforts to help identify and prevent times where prescription medicines are obtained illegally

Last month, Walmart also reached a multi-billion-dollar settlement agreement with state attorneys general to resolve a lawsuit with similar claims.

California is currently assessing settlement terms with CVS, another retail pharmacy chain that attorneys general alleged to have fueled the opioid crisis.

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.